Photodynamic therapy for malignant newly diagnosed supratentorial gliomas

Journal of Clinical Laser Medicine and Surgery

Volumn 14, Issue 5, 1996, Pages 263-270

  Muller, Paul J ^a   Wilson, Brian C ^b  

^a ST MICHAEL'S HOSPITAL   (Canada)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN; LASER TISSUE INTERACTION; ONCOLOGY; PHOTOCHEMICAL REACTIONS; PHOTOSENSITIVITY; RADIATION EFFECTS; TISSUE;

GLIOBLASTOMA MULTIFORME; INTRAVENOUS PORPHYRIN PHOTOSENSITIZERS; LIGHT DOSE; MALIGNANT ASTROCYTOMA; SUPRATENTORIAL GLIOMAS;

PHOTODYNAMIC THERAPY;

DEXAMETHASONE; HEMATOPORPHYRIN DERIVATIVE; INDIUM 111; PHOTOFRIN; PHOTOFRIN II; PHOTOSENSITIZING AGENT; PORPHYRIN; STEROID;

ADULT; AGED; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASTROCYTOMA; CANCER LOCALIZATION; CANCER RADIOTHERAPY; CANCER SURGERY; CLINICAL ARTICLE; CLINICAL FEATURE; CLINICAL TRIAL; DRUG TISSUE LEVEL; DRUG UPTAKE; FEMALE; GLIOBLASTOMA; GLIOMA; HUMAN; INTRATUMORAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; MALE; NEUROLOGIC DISEASE; NONHUMAN; PHASE 1 CLINICAL TRIAL; PHASE 2 CLINICAL TRIAL; PHOTODYNAMIC THERAPY; PROGNOSIS; SURGICAL MORTALITY; SURVIVAL;

EID: 0030273178     PISSN: 10445471     EISSN: None     Source Type: Journal    
DOI: 10.1089/clm.1996.14.263     Document Type: Article

References (44)

1. Black, P. McL. (1991). Brain tumors. Part 1. N. Engl. Med. J. 324, 1471-1476.
2. Mao, et al. (1991). Increasing brain cancer rates in Canada. Can. Med. Assoc. J. 145(12), 1583-1591.
3. Schottenfeld, D., and Fraumen, J.F. (1982). Cancer Epidemiology and Prevention. New York: W.B. Saunders, p. 156.
4. Black, P. McL. (1991). Brain tumors. Part 2. N. Engl. Med. J. 324, 1555-1564.
5. Dirks, P., Bernstein, M., Muller, P., and Tucker, W. (1993). Reoperation for recurrent malignant astrocytoma. Can. J. Surg. 36, 271-275.
6. Mineura, K. (1988). Statistical considerations of therapeutic results in glioblastoma, in Treatment of Glioma. J. Suzuki (ed.). Tokyo: Springer-Verlag, p. 34.
7. Walker, M.D., Alexander, E., Jr., Hunt, W.E., et al. (1978). Evaluation of BCNU and/or radiotherapy in the treatment of anaplastic gliomas. A cooperative clinical trial. J. Neurosurg. 49, 333-343.
8. Walker, M.D., Green, S.B., Byar, D.P., et al. (1980). Randomized comparisons of radiotherapy and nitosoureas for the treatment of malignant glioma after surgery. N. Engl. J. Med. 303, 1323-1329.
9. Boggan, J.E., Walter, R., Edwards, M.S.B., et al. (1984). Distribution of hematoporphyrin derivative in the rat 9L gliosarcoma brain tumour analyzed by digital video fluorescence microscopy. J. Neurosurg. 61, 1113-1119.
10. Hill, J.S., Kaye, A.H., Sawyer, W.H., Morstyn, G., Megison, P.D., and Stylli, S.S. (1990). Selective uptake of hematoporphyrin derivative into human cerebral glioma. Neurosurgery 26, 248-254.
11. Kostron, H., Bellnier, D.A., Lin, C.W., Swartz, M.R., and Martuza, R.L. (1986). Distribution, retention and phototoxicity of hematoporphytin derivative in a rat glioma. Intraneoplastic versus intraperitoneal injection. J. Neurosurg. 64, 768-774.
12. Origitano, T.C., Karesh, S.M., Henkin, R.E., Halama, J.R., and Reichman, O.H. (1993). Photodynamic therapy for intracranial neoplasms: investigations of photosensitizer uptake and distribution using indium-111 photofrin-II single photon emission computed tomography scans in humans with intracranial neoplasms. Neurosurgery 32, 357-364.
13. Stummer, W., Gotz, C., Hassan, A., Heimann, A., and Kempski, O. (1993). Kinetics of Photofrin II in perifocal brain edema. Neurosurgery 33, 1075-1082.
14. Wharen, R.E., Jr., Anderson, R.E., and Laws, E.R. (1983). Quantification of hematoporphyrin derivative in human gliomas, experimental central nervous system tumors, and normal tissue. Neurosurgery 12, 446-450.
15. Dougherty, T.J., Wieshaupt, K.R., and Boyle, D.G. (1985). Photodynamic sensitizers, in: Cancer: Principles and Practice of Oncology. V.T. De Vita, Jr., S. Hellman, and S.A. Rosenberg (eds.). Philadelphia: J.B. Lippincott, Vol. 2, pp. 2272-2279.
16. Muller, P.J., and Wilson, B.C. (1986). An update on the penetration depth of 630 nm light in normal and malignant human brain tissue in vivo. Phys. Med. Biol. 31, 1295-1297.
17. Muller, P.J., and Wilson, B.C. (1987). Photodynamic therapy of malignant primary brain tumours: Clinical effects, postoperative intracranial ICP, and light penetration of brain. Photochem. Photobiol. 46, 929-936.
18. Svaasand, L.O., and Ellingsen, R. (1983). Optical properties of human brain. Photochem. Photobiol. 38, 293-299.
19. Chen, M.K., McKean, J., and Boisvert, D. (1984). Effects of photoradiation on normal rat brain. Neurosurgery 15, 804-810.
20. Dereski, M.O., Chopp, H., Chen, Q., and Hetzel, F. (1989). Normal brain tissue response to photodynamic therapy: Histology, vascular permeability and specific gravity. Photochem. Photobiol. 50, 653-657.
21. Wilson, B., Muller, P.J., and Yanche, J.C. (1986). Instrumentation and light dosimetry for intraoperative photodynamic therapy [PDT] of malignant brain tumours. Phys. Med. Biol. 32, 125-133.
22. Lilge, L., Olivo, M.C., Schatz, S.W., MaGuire, J.A., Patterson, M.S., and Wilson, B.C. (1996). The sensitivity of normal brain and intracranially implanted VX2 tumor to interstitial photodynamic therapy. Br. J. Cancer 73, 332-343.
23. Boggan, J.E., Bolger, C., and Edwards, M.S.B. (1985). Effect of hematoporphyrin derivative photoradiation therapy on survival in the rat 9L gliosarcoma brain-tumor model. J. Neurosurg. 63, 917-921.
24. Cohen, A.M., Wood, W.C., Bamberg, M., and Martuza, R. (1986). Cytotoxicity of human brain tumours by hematoporphyrin derivative. J. Surg. Res. 41, 81-83.
25. Granelli, S.G., Diamond, I., McDonagh, A.F., Wilson, C.B., and Neilsen, S.L. (1975). Photochemotherapy of glioma cells by visible light and hematoporphyrin. Cancer Res. 35, 2556-2570.
26. Hamilton, D., McKean, J.D.S., Tulip, J., Boisvert, D., and Cummins, J. (1986). In vitro photoradiation therapy in the 9L gliosarcoma. J. Neurosurg. 64, 775-779.
27. Ji, Y., Walstad, D., Brown, J.T., and Powers, S.K. (1992). Improved survival from intracavitary photodynamic therapy of rat glioma. Photochem. Photobiol. 56, 385-390.
28. Whelan, H., Schmidt, M.H., Segura, A.D., Mcauliffe, T.L., Bajic, D.M., Murry, K.J., Moulder, J.E., Strother, D.R., Thomas, J.P., and Meyer, G.A. (1993). The role of photodynamic therapy in posterior fossa brain tumors. A preclinical study in the canine glioma model. J. Neurosurg. 79, 562-568.
29. Kaye, A.H., Morstyn, G., and Brownbill, D. (1987). Adjuvant high dose photoradiation therapy for the treatment malignant glioma: A phase 1-2 study. J. Neurosurg. 67, 500-505.
30. Kaye, A.H., Mortstyn, G., and Apuzzo, M.L.J. (1988). Photoradiation therapy and its potential in the management of neurological tumours. J. Neurosurg. 69, 1-14.
31. Kostron, H., Weiser, G., Fritsch, E., et al. (1987). Photodynamic therapy of brain tumours: clinical and neuropathological results. Photochem. Photobiol. 46, 937-943.
32. Laws, E.R., Cortese, D.A., Kinsey, J.H., Eagan, R.T., and Anderson, R.E. (1981). Photoradiation therapy in the treatment of malignant brain tumors: A feasibility study. Neurosurgery 9, 672-678.
33. Laws, E.R., Wharen, R.E., Jr., and Anderson, R.E. (1985). Photodynamic therapy of brain tumours, in: Photodynamic Therapy of Tumours and Other Diseases. G. Jori and C. Perria (eds.). Padova: Libreria Progetto Editore.
34. Laws, E., Wharen, R.E., and Anderson, R.E. (1990). Photoradiation therapy for malignant gliomas, in: Neurosurgical Update I. R.H. Wilkins and S.S. Rengachary (eds.). New York: McGraw-Hill, pp. 255-265.
35. McCulloch, G.A., Forbes, I.R., Lee See, K., Cowled, P.A., Jacka, F.J., and Ward, A.D. (1983). Phototherapy in malignant brain tumors. The Clayton Symposium on Porphyrin Localization and Treatment of Tumors, Santa Barbara, California, April 24-28.
36. Perria, C. (1981). Photodynamic therapy of human gliomas by hematoporphyrin and He-Ne laser. IRCS Med. Sci. 9, 57-58.
37. Perria, C., Carai, M., Falzoi, A., Oninesu, G., Rocca, A., Marrarelli, G., Francaiglia, N., and Jori, G. (1988). Photodynamic therapy of malignant v\brain tumors: Clinical results of, difficulties with, questions about, and future prospects for the neurosurgical applications. Neurosurgery 23, 557-563.
38. Powers, S.K., Cush, S.S., Walstad, D.L., and Kwock, L. (1991). Stereotactic intratumoral photodynamic therapy for recurrent malignant brain tumors. Neurosurgery 29, 688-696.
39. Muller, P.J., and Wilson, B.C. (1995). Photodynamic therapy for recurrent supratentorial gliomas, in: Seminars in Surgical Oncology, Photodynamic Therapy Part II. T.J. Dougherty (ed.). New York: Wiley-Liss, Vol. 11, pp. 347-354.
40. Popovic, E.A., Kaye, A., and Hill, J.S. (1995). Photodynamic therapy of brain tumors. Sem. Surg. Oncol. 11, 335-345.
41. Muller, P.J., and Wilson, B. (1985). Photodynamic therapy [PDT]: Cavitary photo-illumination of malignant cerebral tumours using a laser coupled inflatable balloon, a preliminary report. Can. J. Neurol. Sci. 12, 371-373.
42. Muller, P.J., and Wilson, B.C. (1990). Photodynamic therapy of malignant brain tumours. Lasers Med. Sci. 5, 245-252.
43. Muller, P.J., and Wilson, B.C. (1991). Photodynamic therapy of malignant brain tumours: "field" fractionation. J. Photochem. Photobiol. B: Biol. 9, 117-119.
44. Muller, P.J., and Wilson, B.C. (1992). Photodynamic therapy for brain tumours, in: Photodynamic Therapy of Malignancies a Clinical Manual. J. McCaughan, Jr. (ed.). Boca Raton: CRC Press, pp. 201-211.